120 Participants Needed

tDCS + Cognitive Training for Alcoholism

(tDCS/AUD Trial)

MR
AM
AL
MK
MK
Overseen ByMegan Kazynski, MPH BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether transcranial direct current stimulation (tDCS), a brain stimulation technique, can enhance the effectiveness of cognitive training for individuals with alcohol use disorder. The goal is to determine if this combination can improve thinking skills and reduce relapse rates. Individuals who have struggled with alcohol misuse and have abstained from alcohol for at least a week may be suitable candidates. Participants will receive either real or sham (fake) tDCS during their cognitive training sessions. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance treatment options for alcohol use disorder.

Will I have to stop taking my current medications?

The trial requires that you have been on a stable dose of all your medications (except for as-needed medications) for at least 30 days before starting. So, you won't need to stop your current medications, but they should be stable.

What prior data suggests that this method is safe for cognitive training in alcohol use disorder?

Research shows that transcranial direct current stimulation (tDCS) combined with cognitive training is generally well-tolerated by participants. Studies have found that tDCS can enhance thinking skills in individuals with substance use disorders. Specifically, it boosts self-control, processing speed, and attention, though these improvements are typically small.

Regarding safety, tDCS applies a low electrical current to the scalp, which most people tolerate well. Common side effects are mild and may include tingling, slight itching, or a headache. These effects are usually temporary and not serious.

Overall, while researchers continue to study this treatment, previous studies suggest it is safe, with only minor and manageable side effects.12345

Why are researchers excited about this trial?

Researchers are excited about the combination of transcranial direct current stimulation (tDCS) with cognitive training for treating alcoholism because it offers a novel approach compared to traditional options like medication and behavioral therapy. Unlike standard treatments that mainly focus on managing withdrawal symptoms or modifying behavior, tDCS targets the brain directly by delivering a mild electrical current to enhance cognitive training. This could potentially improve brain function and decision-making, which are often impaired in individuals with alcoholism. Moreover, tDCS is non-invasive and painless, making it an appealing option for those seeking new ways to support recovery.

What evidence suggests that tDCS with cognitive training is effective for alcohol use disorder?

Research has shown that using transcranial direct current stimulation (tDCS) with mental exercises might aid individuals with alcohol use disorder (AUD). In this trial, participants will receive either active tDCS or sham tDCS, both combined with cognitive training. One study found that applying tDCS to the front part of the brain reduced early relapse rates in patients who had completed detox. Another study indicated that AUD patients who received tDCS were more likely to remain sober after rehab. Additionally, tDCS has improved thinking skills in people with substance use disorders, including AUD. This suggests that tDCS could enhance the effectiveness of mental exercises for treating AUD.45678

Who Is on the Research Team?

KO

Kelvin O Lim, MD

Principal Investigator

Minneapolis VA Health Care System, Minneapolis, MN

Are You a Good Fit for This Trial?

This trial is for Veterans aged 22-65 with Alcohol Use Disorder who are receiving outpatient care and have been sober for at least a week. They must be able to consent, not in acute withdrawal, on stable medication doses, and without significant risks from participating or conditions that could affect the study's integrity.

Inclusion Criteria

You have abstained from consuming alcohol for a minimum of one week prior to the onset of study.
You are a veteran receiving outpatient clinical care services for Alcohol Use Disorder through the MVAHCS in the past six months.
You are currently diagnosed with Alcohol Use Disorder, as per the DSM-5 criteria.
See 3 more

Exclusion Criteria

A positive pregnancy test result in a woman of childbearing age/potential as agreed upon by the PI
Contraindications for tDCS (e.g., metallic cranial plates/screws or implanted device, eczema or skin lesions on scalp)
You have trouble remembering things or difficulty understanding things as shown by a test score of 20 or lower on the Montreal Cognitive Assessment.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 10 sessions of cognitive training concurrent with either sham or active tDCS

3 weeks
10 sessions (in-person)

Follow-up

Participants are monitored for changes in binge drinking days, frontal-striatal functional connectivity, and cognitive test scores

2 months
3 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Active Transcranial Direct Current Stimulation (tDCS)
  • Cognitive Training
  • Sham Transcranial Direct Current Stimulation (tDCS)
Trial Overview The study tests if Active Transcranial Direct Current Stimulation (tDCS) paired with cognitive training can improve cognition in those with Alcohol Use Disorder better than a sham tDCS. It aims to see if this method strengthens brain networks and helps recovery.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: tDCS with Cognitive TrainingExperimental Treatment1 Intervention
Group II: Sham tDCS with Cognitive TrainingPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

University of Minnesota

Collaborator

Trials
1,459
Recruited
1,623,000+

Minneapolis Veterans Affairs Medical Center

Collaborator

Trials
77
Recruited
355,000+

Published Research Related to This Trial

In a phase II clinical trial with 33 severe alcoholics, those receiving active transcranial direct current stimulation (tDCS) had a significantly lower relapse rate (50% abstinent) compared to the sham group (11.8% abstinent) after six months, indicating its potential efficacy in reducing relapse risk.
Participants in the tDCS group reported improved quality of life, particularly in the environment domain, suggesting that tDCS not only helps with abstinence but may also enhance overall well-being.
A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence.Klauss, J., Penido Pinheiro, LC., Silva Merlo, BL., et al.[2016]
The study involving 44 children with Fetal Alcohol Spectrum Disorders (FASD) found that transcranial direct current stimulation (tDCS) combined with cognitive training (CT) was feasible and well-tolerated, showing nominal improvements in attention compared to a sham treatment.
While tDCS-augmented CT did not significantly enhance working memory or other cognitive tasks, improvements in attention were correlated with reduced parent-reported attention deficits, suggesting potential benefits of this combined approach for children with FASD.
A randomized controlled trial of transcranial direct-current stimulation and cognitive training in children with fetal alcohol spectrum disorder.Boroda, E., Krueger, AM., Bansal, P., et al.[2020]
Cognitive training has the potential to improve cognitive recovery in individuals with alcohol use disorders (AUDs), although it has been studied infrequently in this population.
While cognitive improvements are often observed with abstinence from alcohol, the effectiveness of training protocols in enhancing performance on tasks that are not directly trained is less consistent, indicating a need for more robust research in this area.
Cognitive training as a component of treatment of alcohol use disorder: A review.Nixon, SJ., Lewis, B.[2020]

Citations

A randomized placebo-controlled clinical trialMultiple sessions of prefrontal tDCS reduced the rate of early relapse in detoxified patients with alcohol-use disorder.
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/32360392/
A randomized controlled trial of transcranial direct-current ...These results demonstrate that tDCS-augmented CT is well tolerated in children with FASD and potentially offers benefits over and above CT alone.
Is Transcranial Direct Current Stimulation Effective for ...Twenty-two studies met the criteria, suggesting tDCS can improve cognitive functions in SUD patients, though results varied. Effectiveness may depend on the ...
Transcranial direct current stimulation combined with ...AUD patients who received tDCS applied to DLPFC showed a significantly higher abstinence rate during the weeks following rehabilitation.
A systematic review and meta-analysis of neuromodulation ...Ninety-four studies were identified that examined the effects of rTMS, tDCS, and DBS on substance use outcomes (eg, craving, consumption, and relapse)
A Meta-Analysis of Transcranial Direct Current Stimulation on ...tDCS can be an effective way to reduce craving of substance or food, and longer multiple stimulus durations in all can more effectively reduce craving.
A randomized, double-blind, sham-controlled trialIn a doubleblind, sham-controlled trial, tDCS+CT improved inhibitory control, processing speed, and divided attention, although the effects were small. •.
Neuromodulation and Cognitive Training for Substance ...This study is testing a new intervention, namely tDCS-Augmented Cognitive Training, to engage these brain biomarkers to improve cognition and improve treatment ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security